Aclid

About

Aclid, Inc. is a biotechnology security and compliance automation platform founded in 2021. Based in New York, the company focuses on biosecurity, biosafety, and biodefense solutions for synthetic biology. Aclid aims to enhance the safety and accessibility of genetic engineering, particularly in response to the growing bioeconomy. The company offers a tech-enabled computational screening platform that automates the identification of pathogenic and risky elements in DNA sequences. Key features include automatic checks against global sanctions and watchlists, real-time sequence screening, compliance certification, and centralized data collaboration for research teams. Aclid's solutions support biosecurity compliance, environmental health and safety management, and early warning systems for biological threats. The platform serves gene synthesis providers, biotech manufacturers, and government entities, helping them manage risks and ensure compliance in their operations.